In addition, FGF21 exerted neuroprotective effects by suppressing the expression of NF-κB in Aβ42-treated SH-SY5Y cells and pro-inflammatory cytokines in the models of PD and ALS [206,211,213]. This evidence concerns the gene FGF21 and Parkinson disease.